SCHEMBL9764810

SCHEMBL9764810

ONCCc1ccc2c(c1)oc1ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.50
CYP2C19 P33261 2/20 0.50
CYP2D6 P10635 1/20 0.50
AHR P35869 2/20 0.47
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
ECE1 P42892 3/20 0.46
MME P08473 1/20 0.46
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
MAPT P10636 1/20 0.46
HPGD P15428 1/20 0.46
RAB9A P51151 5/20 0.45
NPC1 O15118 4/20 0.45
TP53 P04637 1/20 0.45
POLB P06746 1/20 0.45
TSHR P16473 1/20 0.45
MMP12 P39900 1/20 0.44
MMP13 P45452 1/20 0.44
NPSR1 Q6W5P4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19768725 0.84 CYP1A2 (0.57) CYP1A2CYP2C19CYP2D6AHRMEN1
SCHEMBL26007482 0.80 ECE1 (0.47) CYP1A2CYP2C19CYP2D6AHRMEN1
SCHEMBL21510705 0.79 CYP1A2 (0.53) CYP1A2CYP2C19CYP2D6AHRMEN1
SCHEMBL2958769 0.79 AHR (0.53) CYP1A2CYP2C19CYP2D6AHRMEN1
SCHEMBL28263509 0.77 CYP1A2 (0.58) CYP1A2CYP2C19CYP2D6AHRMEN1
SCHEMBL9764821 0.76 KMT2A (0.45) CYP1A2CYP2C19CYP2D6MEN1KMT2A
SCHEMBL21859396 0.75 CYP1A2 (0.53) CYP1A2CYP2C19CYP2D6AHRMEN1
SCHEMBL10306815 0.75 AHR (0.53) CYP1A2CYP2C19CYP2D6AHRMEN1
SCHEMBL30810814 0.75 AHR (0.53) CYP1A2CYP2C19CYP2D6AHRMEN1
SCHEMBL19155292 0.74 AHR (0.52) CYP1A2CYP2C19CYP2D6AHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0422079-A4 TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE 1991-08-21 EP disclosed
EP-0422079-A1 TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE ABBOTT LABORATORIES (US) 1991-04-17 EP disclosed
WO-1989012636-A1 TRICYCLIC LIPOXYGENASE INHIBITING COMPOUNDS, COMPOSITIONS, METHODS OF USE ABBOTT LABORATORIES (US) 1989-12-28 WO disclosed